F.D.A. Cracks Down on ‘Unscrupulous’ Stem Cell Clinics
The Food and Drug Administration (FDA) announced its crackdown on dangerous stem cell clinics. In light of its new proposal, the FDA still maintains its pledge to ease the path to approval for companies and doctors with legitimate treatments in the growing field of stem cell clinics and research.
“The F.D.A.’s proposal is clear evidence of the fact that the regenerative medicine sector has matured and has moved from just a research sector to a development of market ready products,” said Partner Michael Werner.